PSi-guided Propofol Target-controlled Infusion Reduces Sedation-related Adverse Events in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Randomized Controlled Trial

Imagine a medical procedure where a doctor uses a flexible tube to look deep inside the body, navigating the complex plumbing of the bile ducts and pancreas. This procedure, known as endoscopic retrograde cholangiopancreatography, or ERCP, is essential for diagnosing and treating serious blockages and stones. However, the tube must be maneuvered with extreme precision, and even a slight cough or a moment of pain can cause the patient to move, potentially ruining the delicate work or causing injury. To prevent this, patients are given sedation to keep them calm and still. The challenge for the medical team is a delicate balancing act: give enough medicine to ensure the patient is comfortable and motionless, but not so much that their breathing slows down dangerously or their blood pressure drops too low. For years, doctors have relied on checking a patient's responsiveness—tapping their shoulder or asking them to squeeze a hand—to judge if the sedation level is just right. This method, while standard, is like checking the weather by looking out the window only once every few minutes; it misses the sudden changes happening in between.

A new study conducted at the General Hospital of Northern Theater Command in China explores whether a more continuous, electronic way of measuring sedation can make these procedures safer. The researchers focused on a tool called the Patient State Index, or PSi. This device reads electrical signals from the brain, much like a heart monitor reads the heart, to provide a constant number that reflects how deeply a patient is asleep. A lower number means a deeper state of sedation. The team wanted to see if using this real-time brain signal to guide the administration of propofol, a common sedative drug, would lead to fewer complications compared to the traditional method of checking the patient's alertness manually. They enrolled nearly 760 adults scheduled for elective ERCP procedures and randomly assigned them to one of two groups. One group received sedation guided by the traditional manual checks, while the other group had their drug levels adjusted automatically based on the continuous brain signal, aiming to keep the sedation level within a specific, safe range.

The results of the trial were striking. The group guided by the brain signal experienced significantly fewer safety problems. In the group where doctors relied on the traditional manual checks, nearly 40 percent of patients suffered from at least one adverse event, such as a drop in oxygen levels, a need for help to keep their airway open, or a dangerous drop in blood pressure. In contrast, the group guided by the brain signal saw these events in only about 18 percent of patients. This difference was not just a small improvement; it represented a major reduction in risk. Specifically, the brain-guided group had far fewer instances of low oxygen, which is a common and serious concern when patients are deeply sedated. They also required far fewer physical interventions to keep their airways clear, such as lifting the jaw or inserting a tube to help them breathe. Furthermore, the patients in the brain-guided group needed less of the sedative drug overall, which allowed them to wake up and recover about four and a half minutes faster than those in the other group.

Beyond the safety statistics, the experience of the procedure improved for everyone involved. The patients who were guided by the brain signal reported higher satisfaction with their care, and the doctors performing the ERCP procedures were also more satisfied with the conditions. This suggests that the continuous monitoring helped maintain the perfect level of sedation: deep enough to keep the patient still and pain-free, but light enough to avoid suppressing their breathing or heart function. The study found that the actual time the procedure took did not change, nor did the rate of irregular heartbeats, indicating that the new method did not speed up the surgery at the cost of safety or quality. Instead, it simply made the sedation more efficient and predictable.

The researchers noted that while the results are promising, the study was conducted at a single, highly experienced center with carefully selected patients who did not have severe obesity or complex airway issues. This means the findings might look different if applied to a much broader or sicker population. The team also acknowledged that the doctors could not be blinded to the method being used, as the brain monitor was visibly different from the standard checks, which could have influenced how they managed the patients. Despite these limitations, the study provides strong evidence that using a continuous brain signal to guide sedation is a superior strategy to manual checks for this specific type of procedure. It suggests that by listening to the brain's own signals in real time, medical teams can avoid the guesswork of sedation, keeping patients safer and helping them recover more quickly. The authors conclude that while this approach shows great promise, further testing in diverse hospitals and with more complex patients is needed before it becomes the standard for everyone.